Ralph Alexander brings to Amyris over 25 years of experience and proven success in the oil and gas and petrochemicals sector. Currently, Mr. Alexander is the Managing Director at Riverstone LLC. Most recently, Mr. Alexander served as the Chief Executive Officer of Innovene, the olefins and derivatives subsidiary of British Petroleum (BP). more>>

John Doerr is a partner at Kleiner Perkins Caufield & Byers. Mr. Doerr joined KPCB in 1980, and with KPCB's partners backed many of America's best entrepreneurial leaders. more>>

Prior to joining TPG Biotech in 2004, Dr. Geoff Duyk served on the Board of Directors and was President of Research & Development at Exelixis where he led a 550+ person group focused on the discovery and development of small molecule therapeutics. more>>

Samir Kaul recently became a founding partner at Khosla Ventures in California. Prior to Khosla Ventures, Mr. Kaul was a member of the Life Science team at Flagship. more>>

John G. Melo is the Chief Executive Officer of Amyris. Mr. Melo was previously President of U.S. Fuels Operations for British Petroleum. more>>

Jack D. Newman, Ph.D. is the Senior Vice President of Research and a Co-Founder of Amyris. Dr. Newman brings to Amyris over a decade of research in bacterial physiology and genetics. more>>

Neil Renninger, Ph.D. is the Chief Technical Officer and a Co-Founder of Amyris. Dr. Renninger brings to Amyris a cross disciplinary understanding of both the micro-world of strain engineering and the macro-world of chemical engineering. more>>